These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 20223751)
1. Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations. Urwin H; Authier A; Nielsen JE; Metcalf D; Powell C; Froud K; Malcolm DS; Holm I; Johannsen P; Brown J; Fisher EM; van der Zee J; Bruyland M; ; Van Broeckhoven C; Collinge J; Brandner S; Futter C; Isaacs AM Hum Mol Genet; 2010 Jun; 19(11):2228-38. PubMed ID: 20223751 [TBL] [Abstract][Full Text] [Related]
2. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III. Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479 [TBL] [Abstract][Full Text] [Related]
3. Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology. Clayton EL; Mizielinska S; Edgar JR; Nielsen TT; Marshall S; Norona FE; Robbins M; Damirji H; Holm IE; Johannsen P; Nielsen JE; Asante EA; Collinge J; ; Isaacs AM Acta Neuropathol; 2015 Oct; 130(4):511-23. PubMed ID: 26358247 [TBL] [Abstract][Full Text] [Related]
14. Absence of FUS-immunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B gene. Holm IE; Isaacs AM; Mackenzie IR Acta Neuropathol; 2009 Nov; 118(5):719-20. PubMed ID: 19844732 [No Abstract] [Full Text] [Related]
15. A novel splice-site mutation in CHMP2B associated with frontotemporal dementia: The first report from China and literature review. Li C; Wen Y; Zhao M; Wang Y; Li P; Wang L; Wang S Mol Genet Genomic Med; 2023 Aug; 11(8):e2222. PubMed ID: 37272767 [TBL] [Abstract][Full Text] [Related]
16. The role of CHMP2B in frontotemporal dementia. Urwin H; Ghazi-Noori S; Collinge J; Isaacs A Biochem Soc Trans; 2009 Feb; 37(Pt 1):208-12. PubMed ID: 19143633 [TBL] [Abstract][Full Text] [Related]
17. Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B. Zhang Y; Schmid B; Nikolaisen NK; Rasmussen MA; Aldana BI; Agger M; Calloe K; Stummann TC; Larsen HM; Nielsen TT; Huang J; Xu F; Liu X; Bolund L; Meyer M; Bak LK; Waagepetersen HS; Luo Y; Nielsen JE; ; Holst B; Clausen C; Hyttel P; Freude KK Stem Cell Reports; 2017 Mar; 8(3):648-658. PubMed ID: 28216144 [TBL] [Abstract][Full Text] [Related]
18. CHMP2B mutations are not a cause of dementia in Dutch patients with familial and sporadic frontotemporal dementia. Rizzu P; van Mil SE; Anar B; Rosso SM; Donker Kaat L; Heutink P; van Swieten JC Am J Med Genet B Neuropsychiatr Genet; 2006 Dec; 141B(8):944-6. PubMed ID: 16941655 [TBL] [Abstract][Full Text] [Related]
19. Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation. Clayton EL; Mancuso R; Nielsen TT; Mizielinska S; Holmes H; Powell N; Norona F; Larsen JO; Milioto C; Wilson KM; Lythgoe MF; Ourselin S; Nielsen JE; Johannsen P; Holm I; Collinge J; ; Oliver PL; Gomez-Nicola D; Isaacs AM Hum Mol Genet; 2017 Mar; 26(5):873-887. PubMed ID: 28093491 [TBL] [Abstract][Full Text] [Related]
20. CHMP2B mutations are not a common cause of frontotemporal lobar degeneration. Cannon A; Baker M; Boeve B; Josephs K; Knopman D; Petersen R; Parisi J; Dickison D; Adamson J; Snowden J; Neary D; Mann D; Hutton M; Pickering-Brown SM Neurosci Lett; 2006 May; 398(1-2):83-4. PubMed ID: 16431024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]